Sanofi India has informed that it enclosed Certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018 for the period ended 31st March 2025 provided by RTA.
The above information is a part of company’s filings submitted to BSE.